Michael Shapiro to C-Reactive Protein
This is a "connection" page, showing publications Michael Shapiro has written about C-Reactive Protein.
Connection Strength
1.003
-
Zhang W, Speiser JL, Ye F, Tsai MY, Cainzos-Achirica M, Nasir K, Herrington DM, Shapiro MD. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2021 Sep 14; 78(11):1083-1094.
Score: 0.724
-
Shapiro MD, Taub PR, Louie MJ, Lei L, Ballantyne CM. Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials. Atherosclerosis. 2023 Aug; 378:117182.
Score: 0.205
-
Zhou XD, Chen QF, Targher G, Byrne CD, Shapiro MD, Tian N, Xiao T, Sung KC, Lip GYH, Zheng MH. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. J Am Heart Assoc. 2024 Feb 06; 13(3):e032997.
Score: 0.053
-
Broide E, Schopan A, Zaretsky M, Kimchi NA, Shapiro M, Scapa E. Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population. Dig Dis Sci. 2011 Jan; 56(1):197-202.
Score: 0.021